Clinical Trial Update: ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A completed Phase 1 study evaluating gefitinib (Iressa) in combination with concurrent chemotherapy and radiation in locally advanced non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Carcinoma | Phase 1 | Status: COMPLETED